| 1 | TAVR in Patients With Moderate Aortic Stenosis and Heart Failure | 2.3 | 6 | Citations (PDF) |
| 2 | Management of complications after valvular interventions | 3.0 | 13 | Citations (PDF) |
| 3 | Safe and Effective Treatment of Aortic Regurgitation in LVAD Patients Using a Dedicated TAVR Device | 3.0 | 2 | Citations (PDF) |
| 4 | Percutaneous treatment of multivalvular heart disease following previous sternotomy | 0.5 | 0 | Citations (PDF) |
| 5 | Transcatheter Tricuspid Valve Replacement for Recurrent Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair | 0.5 | 2 | Citations (PDF) |
| 6 | Cardiac implantable electronic device implantation and function after transcatheter tricuspid valve replacement | 2.7 | 5 | Citations (PDF) |
| 7 | Predictive Value of CTA-Derived Extracellular Volume for Pacemaker Implantation Post-TAVR in Low-Flow Low-Gradient Aortic Stenosis | 6.1 | 0 | Citations (PDF) |
| 8 | TAVR-in-TAVR with a balloon-expandable valve for paravalvular leak | 2.4 | 6 | Citations (PDF) |
| 9 | Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registry | 1.4 | 9 | Citations (PDF) |
| 10 | Anticoagulation for Atrial Fibrillation in Patients With Surgically Occluded Left Atrial Appendage | 2.3 | 0 | Citations (PDF) |
| 11 | Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study | 2.2 | 59 | Citations (PDF) |
| 12 | Two-Year Clinical Outcomes of Staged Transcatheter Mitral Edge-to-Edge Repair After Transcatheter Aortic Valve Replacement | 1.8 | 4 | Citations (PDF) |
| 13 | A Volume-Based Framework Reconciling COAPT, MITRA-FR, and RESHAPE-HF2 | 2.3 | 14 | Citations (PDF) |
| 14 | TCT-547 Zero-Fluoroscopy Left Atrial Appendage Occlusion With the Watchman FLX Device | 2.3 | 0 | Citations (PDF) |
| 15 | Classification of primary mitral regurgitation using extramitral cardiac involvement in patients undergoing transcatheter edge‐to‐edge repair | 1.7 | 1 | Citations (PDF) |
| 16 | Low-Intensity vs. High-Intensity Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Meta-Analysis of Randomized Controlled Trials | 1.6 | 2 | Citations (PDF) |
| 17 | Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge‐to‐edge repair patients | 1.7 | 2 | Citations (PDF) |
| 18 | CORONARY EVENTS IN VALVE-IN-VALVE TAVR AND NATIVE TAVR - A TWO-YEAR MATCHED COHORT | 2.3 | 0 | Citations (PDF) |
| 19 | PULMONARY ARTERY DILATION AND CLINICAL OUTCOMES FOLLOWING TRANSCATHETER EDGE-EDGE MITRAL VALVE REPAIR | 2.3 | 0 | Citations (PDF) |
| 20 | RETROGRADE APPROACH FOR AV WIRE CROSSING IN TAVR | 2.3 | 0 | Citations (PDF) |
| 21 | Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications | 2.2 | 35 | Citations (PDF) |
| 22 | Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves | 3.0 | 8 | Citations (PDF) |
| 23 | Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement | 1.6 | 13 | Citations (PDF) |
| 24 | Repeat Mitral Transcatheter Edge‐to‐Edge Repair for Recurrent Significant Mitral Regurgitation | 4.0 | 5 | Citations (PDF) |
| 25 | Underestimation of Intraprocedural Tricuspid Valve Pressure Gradient by Echocardiography in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair | 1.4 | 0 | Citations (PDF) |
| 26 | Leaflet thrombosis in transcatheter aortic valve intervention: mechanisms, prevention, and treatment options | 2.4 | 16 | Citations (PDF) |
| 27 | Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure | 3.0 | 0 | Citations (PDF) |
| 28 | TCT-213 Effectiveness of Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement With High Aortic Valve Calcium Burden | 2.3 | 1 | Citations (PDF) |
| 29 | Effect of Ascending Aortic Curvature on Flow in the Sinus and Neo-sinus Following TAVR: A Patient-Specific Study | 3.5 | 4 | Citations (PDF) |
| 30 | Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study | 2.2 | 200 | Citations (PDF) |
| 31 | Single Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials | 0.7 | 13 | Citations (PDF) |
| 32 | The role of flow stasis in transcatheter aortic valve leaflet thrombosis | 2.6 | 37 | Citations (PDF) |
| 33 | Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials | 3.7 | 18 | Citations (PDF) |
| 34 | Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions | 1.7 | 15 | Citations (PDF) |
| 35 | Abnormal wire’s trajectory during edge-to-edge mitral valve repair—a rare case report of inferior vena cava anomaly | 0.5 | 0 | Citations (PDF) |
| 36 | Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation | 3.0 | 154 | Citations (PDF) |
| 37 | Transcatheter Tricuspid Valve Replacement With the EVOQUE System | 3.0 | 129 | Citations (PDF) |
| 38 | The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients | 3.0 | 85 | Citations (PDF) |
| 39 | Characteristics and outcomes of patients screened for transcatheter mitral valve implantation:
1‐year
results from the
CHOICE‐MI
registry | 7.3 | 69 | Citations (PDF) |
| 40 | 5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses | 3.0 | 64 | Citations (PDF) |
| 41 | Minimally Invasive Versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-Risk Patients | 2.3 | 23 | Citations (PDF) |
| 42 | Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement | 5.2 | 31 | Citations (PDF) |
| 43 | Prognostic Value of Increased Mitral Valve Gradient After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation | 3.0 | 47 | Citations (PDF) |
| 44 | Hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) of aortic bioprostheses: An imaging finding or a complication? | 5.6 | 12 | Citations (PDF) |
| 45 | Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI | 2.2 | 2 | Citations (PDF) |
| 46 | Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization | 35.5 | 79 | Citations (PDF) |
| 47 | Commissural Alignment After Balloon-Expandable Transcatheter Aortic Valve Replacement Is Associated With Improved Hemodynamic Outcomes | 3.0 | 29 | Citations (PDF) |
| 48 | Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type | 3.0 | 34 | Citations (PDF) |
| 49 | Sex differences in aortic stenosis: Identification of knowledge gaps for sex-specific personalized medicine | 0.6 | 18 | Citations (PDF) |
| 50 | Comparison of Residual Tricuspid Regurgitation Severity Assessed by Intraprocedural and Postprocedural Echocardiography in Patients Undergoing Transcatheter Tricuspid Valve Repair | 1.4 | 1 | Citations (PDF) |
| 51 | TCT-389 First Report of Percutaneous Left Atrial Appendage Occlusion With Watchman FLX With TEE Guidance and Zero Contrast | 2.3 | 0 | Citations (PDF) |
| 52 | TCT-521 Hemodynamic and Mortality Outcome for Transcatheter Valve in Degenerated Internally Stented Surgical Valves Compared With Other Degenerated Surgical Valves | 2.3 | 0 | Citations (PDF) |
| 53 | Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve Disease | 0.7 | 1 | Citations (PDF) |
| 54 | Catheter ablation of typical and atypical atrial flutters in a patient with transcatheter tricuspid valve replacement | 0.5 | 1 | Citations (PDF) |
| 55 | Late Fabric and Peridevice Leak of Watchman Left Atrial Appendage Occluder During Long-Term Follow-Up | 3.0 | 1 | Citations (PDF) |
| 56 | Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation | 1.8 | 13 | Citations (PDF) |
| 57 | Editorial on the 2021 ISMICS Expert Consensus Statement on TAVR/SAVR | 0.9 | 0 | Citations (PDF) |
| 58 | Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials | 4.0 | 13 | Citations (PDF) |
| 59 | Left-Sided Venous Access | 3.0 | 7 | Citations (PDF) |
| 60 | Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies | 1.9 | 4 | Citations (PDF) |
| 61 | Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement | 5.2 | 41 | Citations (PDF) |
| 62 | Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk | 2.3 | 298 | Citations (PDF) |
| 63 | Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis Hospitalized With Acute Heart Failure | 1.8 | 19 | Citations (PDF) |
| 64 | Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research | 2.2 | 814 | Citations (PDF) |
| 65 | Valve-in-Surgical-Valve With SAPIEN 3 for Transcatheter Aortic Valve Replacement Based on Society of Thoracic Surgeons Predicted Risk of Mortality | 4.8 | 39 | Citations (PDF) |
| 66 | Left ventricular outflow tract area after percutaneous transseptal transcatheter mitral valve implantation: A three‐dimensional transesophageal echocardiography study | 0.9 | 1 | Citations (PDF) |
| 67 | Percutaneous Edge-to-Edge Mitral Valve Repair With the MitraClip System Following Surgical Annuloplasty Ring Dehiscence | 3.0 | 4 | Citations (PDF) |
| 68 | Impact of Percutaneous Edge-to-Edge Repair in Patients With Atrial Functional Mitral Regurgitation | 1.7 | 31 | Citations (PDF) |
| 69 | Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research | 2.3 | 1,145 | Citations (PDF) |
| 70 | Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry | 18.0 | 98 | Citations (PDF) |
| 71 | Feasibility of Coronary Access in Patients With Acute Coronary Syndrome and Previous TAVR | 3.0 | 34 | Citations (PDF) |
| 72 | 2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study | 3.0 | 63 | Citations (PDF) |
| 73 | Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement | 4.8 | 13 | Citations (PDF) |
| 74 | International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes | 1.4 | 167 | Citations (PDF) |
| 75 | Usefulness of Computed Tomography to Predict Mitral Stenosis After Transcatheter Mitral Valve Edge-to-Edge Repair | 1.8 | 6 | Citations (PDF) |
| 76 | Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation | 18.0 | 64 | Citations (PDF) |
| 77 | International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes | 2.3 | 31 | Citations (PDF) |
| 78 | International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes | 2.6 | 98 | Citations (PDF) |
| 79 | Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States | 4.8 | 50 | Citations (PDF) |
| 80 | 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation | 3.0 | 93 | Citations (PDF) |
| 81 | Percutaneous closure of left ventricular pseudoaneurysm using simultaneous transseptal and transapical approach: a case report | 0.5 | 2 | Citations (PDF) |
| 82 | Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk | 16.5 | 127 | Citations (PDF) |
| 83 | Impact of the Geriatric Nutritional Risk Index in Patients Undergoing Transcatheter Aortic Valve Implantation | 1.8 | 14 | Citations (PDF) |
| 84 | Computed tomography angiography-derived extracellular volume fraction predicts early recovery of left ventricular systolic function after transcatheter aortic valve replacement | 1.4 | 35 | Citations (PDF) |
| 85 | Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics | 3.0 | 22 | Citations (PDF) |
| 86 | Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: An Analysis of the Transcatheter Mitral Valve Replacement in Mitral Annular Calcification Global Registry | 4.8 | 21 | Citations (PDF) |
| 87 | Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI | 2.3 | 74 | Citations (PDF) |
| 88 | Impact of Pulmonary Artery Dilatation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement | 3.0 | 6 | Citations (PDF) |
| 89 | Transcatheter Aortic Valve Replacement for Bicuspid Aortic Insufficiency After Valve-Sparing Aortic Root Replacement | 0.5 | 5 | Citations (PDF) |
| 90 | Transcatheter aortic valve implantation in the Asia-Pacific region: is it ready for prime time? | 0.6 | 0 | Citations (PDF) |
| 91 | Balloon-expandable valve-in-valve for a deformed surgical bioprosthesis | 2.2 | 1 | Citations (PDF) |
| 92 | Mechanisms of mitral regurgitation after percutaneous mitral valve repair with the MitraClip | 1.4 | 27 | Citations (PDF) |
| 93 | Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients | 2.6 | 10 | Citations (PDF) |
| 94 | A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement | 34.5 | 500 | Citations (PDF) |
| 95 | Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement | 34.5 | 264 | Citations (PDF) |
| 96 | Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve | 3.0 | 27 | Citations (PDF) |
| 97 | The Impact of Valvuloarterial Impedance on Left Ventricular Geometrical Change after Transcatheter Aortic Valve Replacement: A Comparison between Valvuloarterial Impedance and Mean Pressure Gradient | 2.5 | 1 | Citations (PDF) |
| 98 | Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial | 2.3 | 195 | Citations (PDF) |
| 99 | Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System | 3.0 | 99 | Citations (PDF) |
| 100 | 1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study | 3.0 | 99 | Citations (PDF) |
| 101 | Anticoagulation Therapy After Transcatheter Aortic Valve Replacement | 2.9 | 5 | Citations (PDF) |
| 102 | Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome | 4.0 | 21 | Citations (PDF) |
| 103 | Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement | 4.8 | 39 | Citations (PDF) |
| 104 | Prognostic Value of Computed Tomography–Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis | 6.1 | 43 | Citations (PDF) |
| 105 | One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve | 11.1 | 165 | Citations (PDF) |
| 106 | Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial | 2.2 | 115 | Citations (PDF) |
| 107 | Outcomes of Patients with Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Implantation | 1.8 | 7 | Citations (PDF) |
| 108 | Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System | 3.0 | 33 | Citations (PDF) |
| 109 | Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography | 3.0 | 103 | Citations (PDF) |
| 110 | Bioprosthetic Valve Thrombosis: Insights from Transcatheter and Surgical Implants | 1.6 | 7 | Citations (PDF) |
| 111 | Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement | 2.3 | 277 | Citations (PDF) |
| 112 | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement | 4.0 | 24 | Citations (PDF) |
| 113 | Leaflet immobility and thrombosis in transcatheter aortic valve replacement | 2.2 | 50 | Citations (PDF) |
| 114 | Transcatheter aortic valve replacement for bicuspid aortic valve regurgitation in a 17-year-old patient with congenitally corrected transposition of great arteries: a case report | 0.5 | 4 | Citations (PDF) |
| 115 | Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement | 2.3 | 49 | Citations (PDF) |
| 116 | Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement | 3.0 | 115 | Citations (PDF) |
| 117 | Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series | 7.0 | 50 | Citations (PDF) |
| 118 | Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves | 2.3 | 262 | Citations (PDF) |
| 119 | Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial | 62.1 | 130 | Citations (PDF) |
| 120 | Transcatheter aortic valve replacement in bicuspid aortic valve stenosis | 5.6 | 9 | Citations (PDF) |
| 121 | Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR | 3.0 | 33 | Citations (PDF) |
| 122 | Timing and Outcomes of Percutaneous Coronary Intervention in Patients Who Underwent Transcatheter Aortic Valve Implantation | 1.8 | 44 | Citations (PDF) |
| 123 | Coronary Protection to Prevent Coronary Obstruction During TAVR | 3.0 | 84 | Citations (PDF) |
| 124 | Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement | 34.5 | 767 | Citations (PDF) |
| 125 | Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk | 18.0 | 34 | Citations (PDF) |
| 126 | Coronary Access After TAVR | 3.0 | 150 | Citations (PDF) |
| 127 | Chimney Stenting for Coronary Occlusion During TAVR | 3.0 | 161 | Citations (PDF) |
| 128 | Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies | 4.0 | 30 | Citations (PDF) |
| 129 | Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients | 18.0 | 135 | Citations (PDF) |
| 130 | New-Generation Transcatheter Aortic Valves in Patients With Small Aortic Annuli ― Comparison of Balloon- and Self-Expandable Valves in Asian Patients ― | 1.7 | 13 | Citations (PDF) |
| 131 | Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement | 18.0 | 14 | Citations (PDF) |
| 132 | Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular Calcification | 0.5 | 6 | Citations (PDF) |
| 133 | Late Contained Aortic Root Rupture After Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis | 3.0 | 0 | Citations (PDF) |
| 134 | Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses | 3.0 | 68 | Citations (PDF) |
| 135 | Prosthetic Valve Endocarditis After TAVR and SAVR | 18.0 | 110 | Citations (PDF) |
| 136 | Infective Endocarditis Following Transcatheter Aortic Valve Replacement | 4.8 | 52 | Citations (PDF) |
| 137 | Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial | 4.0 | 67 | Citations (PDF) |
| 138 | Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation | 3.0 | 52 | Citations (PDF) |
| 139 | Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement | 2.3 | 48 | Citations (PDF) |
| 140 | Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis | 2.3 | 84 | Citations (PDF) |
| 141 | Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement | 3.0 | 266 | Citations (PDF) |
| 142 | Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial | 1.0 | 77 | Citations (PDF) |
| 143 | Predictors and Outcomes of Persistent Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation | 1.8 | 19 | Citations (PDF) |
| 144 | Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration) | 2.2 | 140 | Citations (PDF) |
| 145 | Might Coronary Flow Influence Transcatheter Heart Valve Neo-Sinus Thrombosis? | 4.8 | 9 | Citations (PDF) |
| 146 | Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke | 16.5 | 294 | Citations (PDF) |
| 147 | New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial | 2.2 | 140 | Citations (PDF) |
| 148 | Clinical Outcomes of Transcatheter Aortic Valve Implantation in Patients With Extremely Large Annulus and SAPIEN 3 Dimensions Based on Post-Procedural Computed Tomography | 1.7 | 18 | Citations (PDF) |
| 149 | Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients | 34.5 | 4,477 | Citations (PDF) |
| 150 | Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter Registry | 2.6 | 12 | Citations (PDF) |
| 151 | Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves | 11.1 | 50 | Citations (PDF) |
| 152 | Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk | 18.0 | 168 | Citations (PDF) |
| 153 | Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis | 2.2 | 86 | Citations (PDF) |
| 154 | Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis | 3.0 | 74 | Citations (PDF) |
| 155 | Mid-Term Valve-Related Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring Replacement | 2.3 | 113 | Citations (PDF) |
| 156 | Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification | 2.2 | 352 | Citations (PDF) |
| 157 | Characterization of aortic root geometry in transcatheter aortic valve replacement patients | 1.7 | 15 | Citations (PDF) |
| 158 | Transcatheter and Doppler waveform correlation in transcatheter aortic valve replacement | 4.5 | 2 | Citations (PDF) |
| 159 | Association of postprocedural aortic regurgitation with mitral regurgitation worsened after transcatheter aortic valve replacement | 0.9 | 2 | Citations (PDF) |
| 160 | 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification | 2.3 | 353 | Citations (PDF) |
| 161 | Percutaneous Management of Aortic Root Rupture During Transcatheter Aortic Valve Replacement With Coil Embolization | 4.8 | 1 | Citations (PDF) |
| 162 | Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves | 18.0 | 469 | Citations (PDF) |
| 163 | Outcomes in 937 Intermediate-Risk Patients Undergoing Surgical Aortic Valve Replacement in PARTNER-2A | 2.3 | 26 | Citations (PDF) |
| 164 | Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve | 3.0 | 84 | Citations (PDF) |
| 165 | Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis | 16.5 | 163 | Citations (PDF) |
| 166 | Recurrent severe aortic stenosis after transfemoral transcatheter valve-in-valve-in-valve replacement | 2.6 | 1 | Citations (PDF) |
| 167 | Computed tomography characteristics of the aortic valve and the geometry of SAPIEN 3 transcatheter heart valve in patients with bicuspid aortic valve disease | 1.4 | 69 | Citations (PDF) |
| 168 | Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis | 2.3 | 204 | Citations (PDF) |
| 169 | Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon‐Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning | 1.7 | 11 | Citations (PDF) |
| 170 | Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement | 1.7 | 8 | Citations (PDF) |
| 171 | Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies | 1.7 | 40 | Citations (PDF) |
| 172 | Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry | 2.9 | 29 | Citations (PDF) |
| 173 | Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry | 2.2 | 398 | Citations (PDF) |
| 174 | Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial | 2.3 | 75 | Citations (PDF) |
| 175 | Outcomes of Self-Expanding vs. Balloon-Expandable Transcatheter Heart Valves for the Treatment of Degenerated Aortic Surgical Bioprostheses ― A Propensity Score-Matched Comparison ― | 1.7 | 32 | Citations (PDF) |
| 176 | Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial | 1.6 | 4 | Citations (PDF) |
| 177 | Cancellation of the Cardiac Catheterization Lab After Activation for ST-Segment–Elevation Myocardial Infarction | 4.1 | 18 | Citations (PDF) |
| 178 | Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve | 0.5 | 5 | Citations (PDF) |
| 179 | Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement | 3.0 | 45 | Citations (PDF) |
| 180 | Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve | 3.0 | 53 | Citations (PDF) |
| 181 | Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial | 1.6 | 0 | Citations (PDF) |
| 182 | Response by Sharma et al to Letter Regarding Article, “The Fluid Mechanics of Transcatheter Heart Valve Leaflet Thrombosis in the Neosinus” | 18.0 | 0 | Citations (PDF) |
| 183 | Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and its Impact on Valvular Function and Coronary Filling | 3.0 | 98 | Citations (PDF) |
| 184 | Diagnosis and Outcomes of Transcatheter Aortic Valve Implantation in Bicuspid Aortic Valve Stenosis | 1.4 | 10 | Citations (PDF) |
| 185 | High-pressure post-dilation following transcatheter valve-in-valve implantation in small surgical valves | 3.0 | 10 | Citations (PDF) |
| 186 | Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement | 2.2 | 84 | Citations (PDF) |
| 187 | Outcome of paravalvular leak repair after transcatheter aortic valve replacement with a balloon‐expandable prosthesis | 1.7 | 10 | Citations (PDF) |
| 188 | Geometric changes in ventriculoaortic complex after transcatheter aortic valve replacement and its association with post-procedural prosthesis–patient mismatch: an intraprocedural 3D-TEE study | 1.4 | 8 | Citations (PDF) |
| 189 | Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair | 3.0 | 101 | Citations (PDF) |
| 190 | Short‐term results of alcohol septal ablation as a bail‐out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification | 1.7 | 96 | Citations (PDF) |
| 191 | A Highly Predictive Risk Model for Pacemaker Implantation After TAVR | 6.1 | 242 | Citations (PDF) |
| 192 | Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses | 3.0 | 160 | Citations (PDF) |
| 193 | Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses | 2.3 | 318 | Citations (PDF) |
| 194 | Effect of ascending aortic dimension on acute procedural success following self-expanding transcatheter aortic valve replacement | 2.2 | 23 | Citations (PDF) |
| 195 | Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis | 6.1 | 186 | Citations (PDF) |
| 196 | Long‐term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus‐eluting stents for the treatment of cardiac allograft vasculopathy | 1.7 | 26 | Citations (PDF) |
| 197 | Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis | 2.3 | 461 | Citations (PDF) |
| 198 | Severe aortic stenosis with low aortic valve calcification: characteristics and outcome following transcatheter aortic valve implantation | 1.4 | 30 | Citations (PDF) |
| 199 | Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients | 34.5 | 2,773 | Citations (PDF) |
| 200 | Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study | 62.1 | 866 | Citations (PDF) |
| 201 | Long-Term Valve Performance of TAVR and SAVR | 6.1 | 91 | Citations (PDF) |
| 202 | Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial | 11.1 | 81 | Citations (PDF) |
| 203 | Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve | 11.1 | 206 | Citations (PDF) |
| 204 | Relation of Residual Mitral Regurgitation Despite Elevated Mitral Gradients to Risk of Heart Failure Hospitalization After MitraClip Repair | 1.8 | 27 | Citations (PDF) |
| 205 | Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings | 2.3 | 203 | Citations (PDF) |
| 206 | Relation Between Left Ventricular Outflow Tract Calcium and Mortality Following Transcatheter Aortic Valve Implantation | 1.8 | 21 | Citations (PDF) |
| 207 | ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design | 2.7 | 86 | Citations (PDF) |
| 208 | The Fluid Mechanics of Transcatheter Heart Valve Leaflet Thrombosis in the Neosinus | 18.0 | 220 | Citations (PDF) |
| 209 | Staging classification of aortic stenosis based on the extent of cardiac damage | 2.2 | 683 | Citations (PDF) |
| 210 | Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation | 2.3 | 296 | Citations (PDF) |
| 211 | Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement | 4.8 | 32 | Citations (PDF) |
| 212 | Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk | 11.1 | 131 | Citations (PDF) |
| 213 | Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves | 2.2 | 211 | Citations (PDF) |
| 214 | Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement | 2.3 | 496 | Citations (PDF) |
| 215 | Impact of Mitral Annular Displacement on Left Ventricular Diastolic Function Improvement After Transcatheter Aortic Valve Implantation | 1.7 | 6 | Citations (PDF) |
| 216 | Transcatheter Aortic Valve Replacement With Different Valve Types in Elliptic Aortic Annuli | 1.7 | 17 | Citations (PDF) |
| 217 | Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment | 1.6 | 3 | Citations (PDF) |
| 218 | Characteristics and outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis with low flow | 3.0 | 15 | Citations (PDF) |
| 219 | Comparison of SAPIEN 3 and SAPIEN XT transcatheter heart valve stent-frame expansion: evaluation using multi-slice computed tomography | 1.4 | 56 | Citations (PDF) |
| 220 | A Bicuspid Aortic Valve Imaging Classification for the TAVR Era | 6.1 | 234 | Citations (PDF) |
| 221 | Prosthetic Heart Valve Thrombosis | 2.3 | 456 | Citations (PDF) |
| 222 | Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients | 34.5 | 4,769 | Citations (PDF) |
| 223 | Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis | 62.1 | 990 | Citations (PDF) |
| 224 | Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis | 2.2 | 338 | Citations (PDF) |
| 225 | Elevated immune monitoring as measured by increased adenosine triphosphate production in activated lymphocytes is associated with accelerated development of cardiac allograft vasculopathy after cardiac transplantation | 1.1 | 5 | Citations (PDF) |
| 226 | Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves | 34.5 | 46 | Citations (PDF) |
| 227 | Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure | 4.8 | 97 | Citations (PDF) |
| 228 | Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) | 4.8 | 174 | Citations (PDF) |
| 229 | Accreditation and funding for a 24‐month advanced interventional cardiology fellowship program: A call‐to‐action for optimal training of the next generation of interventionalists | 1.7 | 16 | Citations (PDF) |
| 230 | Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial | 2.3 | 85 | Citations (PDF) |
| 231 | The outcomes of transcatheter aortic valve replacement in a cohort of patients with end‐stage renal disease | 1.7 | 28 | Citations (PDF) |
| 232 | Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safety | 1.7 | 70 | Citations (PDF) |
| 233 | Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization | 3.0 | 28 | Citations (PDF) |
| 234 | Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death | 16.5 | 309 | Citations (PDF) |
| 235 | One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis | 18.0 | 179 | Citations (PDF) |
| 236 | Aortic Angulation Attenuates Procedural Success Following Self-Expandable But Not Balloon-Expandable TAVR | 6.1 | 106 | Citations (PDF) |
| 237 | Transcatheter Aortic Valve Replacement Using the Portico System: 10 Things to Remember | 1.3 | 20 | Citations (PDF) |
| 238 | Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety | 2.6 | 35 | Citations (PDF) |
| 239 | Balloon‐expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification | 1.7 | 12 | Citations (PDF) |
| 240 | Impact of body mass index on the outcomes following transcatheter aortic valve implantation | 1.7 | 26 | Citations (PDF) |
| 241 | Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Technical performance | 1.7 | 63 | Citations (PDF) |
| 242 | Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting | 2.3 | 99 | Citations (PDF) |
| 243 | Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation | 1.8 | 35 | Citations (PDF) |
| 244 | 3D Assessment of Features Associated With Transvalvular Aortic Regurgitation After TAVR | 6.1 | 17 | Citations (PDF) |
| 245 | The clinical impact of vascular complications as defined by VARC-1 vs. VARC-2 in patients following transcatheter aortic valve implantation | 3.0 | 11 | Citations (PDF) |
| 246 | Will PARTNER change my practice? Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A trial – transcatheter or surgical aortic-valve replacement in intermediate-risk patients | 3.0 | 6 | Citations (PDF) |
| 247 | Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing? | 3.0 | 10 | Citations (PDF) |
| 248 | Response to Letters Regarding Article, “Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry” | 18.0 | 4 | Citations (PDF) |
| 249 | Significant Reduction in Mitral Regurgitation Volume Is the Main Contributor for Increase in Systolic Forward Flow in Patients with Functional Mitral Regurgitation after Transcatheter Aortic Valve Replacement: Hemodynamic Analysis Using Echocardiography | 0.9 | 9 | Citations (PDF) |
| 250 | Major thrombocytopenia after balloon‐expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement | 1.7 | 50 | Citations (PDF) |
| 251 | Transfemoral Access Assessment for Transcatheter Aortic Valve Replacement | 2.9 | 53 | Citations (PDF) |
| 252 | The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement | 2.7 | 116 | Citations (PDF) |
| 253 | Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement | 3.0 | 41 | Citations (PDF) |
| 254 | Response to Letter Regarding Article “Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005–2009)” | 18.0 | 1 | Citations (PDF) |
| 255 | Response to Letter Regarding Article, “Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy” | 18.0 | 2 | Citations (PDF) |
| 256 | A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery | 3.0 | 101 | Citations (PDF) |
| 257 | Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial | 2.3 | 52 | Citations (PDF) |
| 258 | Cardiopulmonary bypass and intra‐aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy | 1.7 | 27 | Citations (PDF) |
| 259 | Outcomes of Inoperable Symptomatic Aortic Stenosis Patients Not Undergoing Aortic Valve Replacement | 3.0 | 56 | Citations (PDF) |
| 260 | Meta-Analysis of the Impact of Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Implantation | 1.8 | 115 | Citations (PDF) |
| 261 | Comparison of Outcomes of Balloon Aortic Valvuloplasty Plus Percutaneous Coronary Intervention Versus Percutaneous Aortic Balloon Valvuloplasty Alone During the Same Hospitalization in the United States | 1.8 | 16 | Citations (PDF) |
| 262 | Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement | 3.0 | 506 | Citations (PDF) |
| 263 | Cellular Postconditioning | 4.4 | 86 | Citations (PDF) |
| 264 | Porcelain Aorta | 18.0 | 99 | Citations (PDF) |
| 265 | 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial | 62.1 | 1,637 | Citations (PDF) |
| 266 | 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial | 62.1 | 836 | Citations (PDF) |
| 267 | Infective Endocarditis After Transcatheter Aortic Valve Implantation | 18.0 | 265 | Citations (PDF) |
| 268 | Alternative access for balloon-expandable transcatheter aortic valve replacement: Comparison of the transaortic approach using right anterior thoracotomy to partial J-sternotomy | 2.6 | 10 | Citations (PDF) |
| 269 | Impact of Device Landing Zone Calcification on Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: A Real-Time Three-Dimensional Transesophageal Echocardiographic Study | 3.4 | 19 | Citations (PDF) |
| 270 | Coronary Obstruction in Transcatheter Aortic Valve-in-Valve Implantation | 4.8 | 250 | Citations (PDF) |
| 271 | Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States | 6.1 | 66 | Citations (PDF) |
| 272 | Assessment of Post-Procedural Aortic Regurgitation After TAVR | 6.1 | 30 | Citations (PDF) |
| 273 | Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves | 34.5 | 983 | Citations (PDF) |
| 274 | Changes in Speckle Tracking Echocardiography Measures of Ventricular Function after Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve in the Pulmonary Position | 0.9 | 9 | Citations (PDF) |
| 275 | Mitral Annulus Calcification | 2.3 | 418 | Citations (PDF) |
| 276 | Chronic pacing and adverse outcomes after transcatheter aortic valve implantationHeart, 2015, 101, 1665-1671 | 3.9 | 126 | Citations (PDF) |
| 277 | Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥90 Years Versus <90 Years | 1.8 | 35 | Citations (PDF) |
| 278 | Speckle-Tracking Echocardiographic Measures of Right Ventricular Function Correlate With Improvement in Exercise Function After Percutaneous Pulmonary Valve Implantation | 3.4 | 30 | Citations (PDF) |
| 279 | Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation | 2.2 | 165 | Citations (PDF) |
| 280 | Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation | 1.8 | 34 | Citations (PDF) |
| 281 | Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy | 2.2 | 82 | Citations (PDF) |
| 282 | Leptin enhances endothelial cell differentiation and angiogenesis in murine embryonic stem cells | 2.5 | 15 | Citations (PDF) |
| 283 | Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients | 3.0 | 81 | Citations (PDF) |
| 284 | The ABS mother-daughter platforms | 3.0 | 4 | Citations (PDF) |
| 285 | A porcine coronary stent modelof increased neointima formation in the left anterior descending coronary artery | 0.1 | 1 | Citations (PDF) |
| 286 | Allogeneic Cardiospheres Delivered via Percutaneous Transendocardial Injection Increase Viable Myocardium, Decrease Scar Size, and Attenuate Cardiac Dilatation in Porcine Ischemic Cardiomyopathy | 2.3 | 67 | Citations (PDF) |
| 287 | A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation | 1.4 | 179 | Citations (PDF) |
| 288 | Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience | 2.2 | 222 | Citations (PDF) |
| 289 | Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: A comparison with surgical cut‐down and closure | 1.7 | 74 | Citations (PDF) |
| 290 | Device Landing Zone Calcification Predicts Significant Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: A Real Time Three‐Dimensional Transesophageal Echocardiography Study | 0.9 | 2 | Citations (PDF) |
| 291 | Clinical and Angiographic Outcomes with Everolimus Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy | 1.3 | 18 | Citations (PDF) |
| 292 | Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy | 18.0 | 177 | Citations (PDF) |
| 293 | Letter by Makkar et al Regarding Article, “Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions” | 13.1 | 2 | Citations (PDF) |
| 294 | Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction | 2.3 | 502 | Citations (PDF) |
| 295 | Long-Term Outcomes of Percutaneous Coronary Interventions or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease in Octogenarians (from a Drug-Eluting stent for LefT main Artery Registry Substudy) | 1.8 | 27 | Citations (PDF) |
| 296 | Stratification of Outcomes After Transcatheter Aortic Valve Replacement According to Surgical Inoperability for Technical Versus Clinical Reasons | 2.3 | 66 | Citations (PDF) |
| 297 | Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial/Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry | 3.0 | 47 | Citations (PDF) |
| 298 | Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry) | 1.8 | 14 | Citations (PDF) |
| 299 | Outcomes of Patients With Chronic Lung Disease and Severe Aortic Stenosis Treated With Transcatheter Versus Surgical Aortic Valve Replacement or Standard Therapy | 2.3 | 109 | Citations (PDF) |
| 300 | Bleeding Complications After Surgical Aortic Valve Replacement Compared With Transcatheter Aortic Valve Replacement | 2.3 | 193 | Citations (PDF) |
| 301 | Outcomes After Transfemoral Transcatheter Aortic Valve Replacement | 3.0 | 29 | Citations (PDF) |
| 302 | Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes | 18.0 | 158 | Citations (PDF) |
| 303 | Comprehensive Analysis of Mortality Among Patients Undergoing TAVR | 2.3 | 85 | Citations (PDF) |
| 304 | Outcomes With Post-Dilation Following Transcatheter Aortic Valve Replacement | 3.0 | 109 | Citations (PDF) |
| 305 | Effect of Transcatheter Aortic Valve Replacement on the Mitral Valve Apparatus and Mitral Regurgitation | 2.9 | 45 | Citations (PDF) |
| 306 | Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated With Decreased Hospitalizations | 3.0 | 143 | Citations (PDF) |
| 307 | Percutaneous Aortic Balloon Valvotomy in the United States: A 13-Year Perspective | 2.0 | 57 | Citations (PDF) |
| 308 | The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial | 2.6 | 68 | Citations (PDF) |
| 309 | Balloon Mitral Valvuloplasty in the United States: A 13-Year Perspective | 2.0 | 38 | Citations (PDF) |
| 310 | Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation | 2.3 | 609 | Citations (PDF) |
| 311 | Aortic Annular Sizing for Transcatheter Aortic Valve Replacement Using Cross-Sectional 3-Dimensional Transesophageal Echocardiography | 2.3 | 162 | Citations (PDF) |
| 312 | Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Ostial/Mid-Shaft Lesions Versus Distal Bifurcation Lesions in Unprotected Left Main Coronary Artery | 3.0 | 84 | Citations (PDF) |
| 313 | Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy or Embolization | 2.3 | 156 | Citations (PDF) |
| 314 | Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial | 2.3 | 59 | Citations (PDF) |
| 315 | Comparison of Transcatheter and Surgical Aortic Valve Replacement in Severe Aortic Stenosis | 2.3 | 235 | Citations (PDF) |
| 316 | Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction | 18.0 | 107 | Citations (PDF) |
| 317 | Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement | 0.1 | 46 | Citations (PDF) |
| 318 | Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement | 18.0 | 158 | Citations (PDF) |
| 319 | Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement | 18.0 | 564 | Citations (PDF) |
| 320 | Early Echocardiographic Changes After Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve in the Pulmonary Position | 0.9 | 14 | Citations (PDF) |
| 321 | Pre‐emptive positioning of a coronary stent in the left anterior descending artery for left main protection: A prerequisite for transcatheter aortic valve‐in‐valve implantation for failing stentless bioprostheses? | 1.7 | 35 | Citations (PDF) |
| 322 | Leaflet length and left main coronary artery occlusion following transcatheter aortic valve replacement | 1.7 | 25 | Citations (PDF) |
| 323 | How should I treat severe paravalvular leakage after TAVI? | 3.0 | 1 | Citations (PDF) |
| 324 | Glycoprotein IIb/IIIa Receptor Antagonists | 3.2 | 1 | Citations (PDF) |
| 325 | Transcatheter Versus Surgical Aortic-Valve Replacement in High-Risk Patients | 0.1 | 113 | Citations (PDF) |
| 326 | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | 62.1 | 1,368 | Citations (PDF) |
| 327 | Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement | 34.5 | 2,205 | Citations (PDF) |
| 328 | Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis | 34.5 | 1,294 | Citations (PDF) |
| 329 | Cross-Sectional Computed Tomographic Assessment Improves Accuracy of Aortic Annular Sizing for Transcatheter Aortic Valve Replacement and Reduces the Incidence of Paravalvular Aortic Regurgitation | 2.3 | 474 | Citations (PDF) |
| 330 | Transcatheter Aortic Valve Replacement With the St. Jude Medical Portico Valve | 2.3 | 122 | Citations (PDF) |
| 331 | Vascular Complications After Transcatheter Aortic Valve Replacement | 2.3 | 513 | Citations (PDF) |
| 332 | Drug-Eluting Stent for Left Main Coronary Artery Disease | 3.0 | 127 | Citations (PDF) |
| 333 | Comparison of long‐term outcomes of drug‐eluting stents and bare metal stents for saphenous vein graft stenosis | 1.7 | 7 | Citations (PDF) |
| 334 | Meta‐analysis of complications in aortic valve replacement: Comparison of Medtronic‐Corevalve, Edwards‐Sapien and surgical aortic valve replacement in 8,536 patients | 1.7 | 111 | Citations (PDF) |
| 335 | Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation | 3.0 | 11 | Citations (PDF) |
| 336 | Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients | 34.5 | 6,052 | Citations (PDF) |
| 337 | Contemporary Application of Cardiovascular Hemodynamics: Transcatheter Aortic Valve Interventions | 1.5 | 5 | Citations (PDF) |
| 338 | Intramyocardial Injection of Autologous Cardiospheres or Cardiosphere-Derived Cells Preserves Function and Minimizes Adverse Ventricular Remodeling in Pigs With Heart Failure Post-Myocardial Infarction | 2.3 | 234 | Citations (PDF) |
| 339 | Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position | 2.3 | 259 | Citations (PDF) |
| 340 | Contemporary Application of Cardiovascular Hemodynamics: Transcatheter Mitral Valve Interventions | 1.5 | 14 | Citations (PDF) |
| 341 | Predictive Accuracy of SYNTAX Score for Predicting Long-Term Outcomes of Unprotected Left Main Coronary Artery Revascularization | 1.8 | 94 | Citations (PDF) |
| 342 | Transcatheter Aortic Valve Implantation: Patient Selection and Procedural Considerations | 1.0 | 2 | Citations (PDF) |
| 343 | Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis | 18.0 | 300 | Citations (PDF) |
| 344 | PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years | 0.0 | 0 | Citations (PDF) |
| 345 | Meta-Analysis of Incidence, Clinical Characteristics and Implications of Stent Fracture | 1.8 | 105 | Citations (PDF) |
| 346 | Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery | 34.5 | 6,915 | Citations (PDF) |
| 347 | Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue | 2.3 | 268 | Citations (PDF) |
| 348 | New Paradigms of Myocardial Regeneration Post-Infarction | 3.0 | 27 | Citations (PDF) |
| 349 | A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial) | 3.0 | 319 | Citations (PDF) |
| 350 | A Meta-Analysis of 3,773 Patients Treated With Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Coronary Artery Stenosis | 3.0 | 115 | Citations (PDF) |
| 351 | Testing of Intra-Myocardial Cell Therapy in a Large Animal Model of Myocardial Infarction | 0.9 | 0 | Citations (PDF) |
| 352 | Comparison of Coronary Artery Bypass Surgery and Percutaneous Drug-Eluting Stent Implantation for Treatment of Left Main Coronary Artery Stenosis | 3.0 | 76 | Citations (PDF) |
| 353 | The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model | 2.2 | 13 | Citations (PDF) |
| 354 | Comparison of bypass surgery with drug‐eluting stents for diabetic patients with multivessel disease | 2.2 | 58 | Citations (PDF) |
| 355 | Stent fracture associated with drug-eluting stents: Clinical characteristics and implications | 1.7 | 167 | Citations (PDF) |
| 356 | Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction | 1.7 | 17 | Citations (PDF) |
| 357 | Percutaneous Left Ventricular Support Devices | 1.5 | 39 | Citations (PDF) |
| 358 | Comparison of Coronary Artery Bypass Surgery With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease | 2.3 | 308 | Citations (PDF) |
| 359 | Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties | 2.2 | 180 | Citations (PDF) |
| 360 | Coronary sinus is dilated and outwardly displaced in patients with mitral regurgitation: Quantitative Angiographic analysis | 1.7 | 24 | Citations (PDF) |
| 361 | Intracoronary Administration of Abciximab During Percutaneous Coronary Interventions: Should This Be the Routine and Preferred Approach? | 2.5 | 12 | Citations (PDF) |
| 362 | Percutaneous left ventricular assist device: “TandemHeart” for high-risk coronary intervention | 1.7 | 86 | Citations (PDF) |
| 363 | Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts | 1.7 | 83 | Citations (PDF) |
| 364 | Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction | 2.5 | 108 | Citations (PDF) |
| 365 | Stem-Cell Repair of Infarcted Myocardium: Ready for Clinical Application? | 0.1 | 6 | Citations (PDF) |
| 366 | Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation–fibrinolysis system | 4.9 | 56 | Citations (PDF) |
| 367 | New strategies in the percutaneous management of coronary artery fistulae: A case report | 1.7 | 14 | Citations (PDF) |
| 368 | Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease | 1.7 | 41 | Citations (PDF) |
| 369 | Intracoronary β‐irradiation enhances balloon‐injury‐induced tissue factor expression in the porcine injury model | 0.6 | 5 | Citations (PDF) |
| 370 | Partial restoration of myocardial function and perfusion by cell therapy following myocardial infarction | 1.6 | 8 | Citations (PDF) |
| 371 | Stem-Cell Transplantation in Myocardial Infarction: A Status Report | 9.6 | 90 | Citations (PDF) |
| 372 | Mending the broken heart | 2.0 | 2 | Citations (PDF) |
| 373 | Mesenchymal Stem Cell Injection Induces Cardiac Nerve Sprouting and Increased Tenascin Expression in a Swine Model of Myocardial Infarction | 2.1 | 120 | Citations (PDF) |
| 374 | A Prospective, Nonrandomized, Open-Labeled Pilot Study Investigating the Use of Magnesium in Patients Undergoing Nonacute Percutaneous Coronary Intervention with Stent Implantation | 2.5 | 17 | Citations (PDF) |
| 375 | Stem Cell Repair of Infarcted Myocardium | 18.0 | 150 | Citations (PDF) |
| 376 | Local Drug Delivery via a Coronary Stent With Programmable Release Pharmacokinetics | 18.0 | 169 | Citations (PDF) |
| 377 | Increased Expression of Macrophage Colony–Stimulating Factor After Coronary Artery Balloon Injury Is Inhibited by Intracoronary Brachytherapy | 18.0 | 13 | Citations (PDF) |
| 378 | Validation of the localization of the target tissue for intracoronary brachytherapy | 0.1 | 1 | Citations (PDF) |
| 379 | Leakage of a liquid 188Re-filled balloon system during intracoronary brachytherapy. A case report | 0.6 | 20 | Citations (PDF) |
| 380 | Effects of a positron-emitting VANADIUM-48 nitinol stent on experimental restenosis in porcine coronary arteries | 0.6 | 11 | Citations (PDF) |
| 381 | Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis | 2.2 | 118 | Citations (PDF) |
| 382 | A β-emitting Liquid Isotope Filled Balloon Markedly Inhibits Restenosis in Stented Porcine Coronary Arteries | 2.3 | 5 | Citations (PDF) |
| 383 | Primary Reperfusion in Acute Myocardial Infarction With ReoPro and Heparin: Interim Results of ReoMI Pilot Study | 2.3 | 1 | Citations (PDF) |
| 384 | Long-Term Follow-Up of a High Risk Cohort After Stent Implantation in Saphenous Vein Grafts | 2.3 | 33 | Citations (PDF) |
| 385 | Effects of GP IIb/IIIa Receptor Monoclonal Antibody (7E3), Heparin, and Aspirin in an Ex Vivo Canine Arteriovenous Shunt Model of Stent Thrombosis | 18.0 | 32 | Citations (PDF) |
| 386 | Clopidogrel is more effective than aspirin in inhibiting acute stent thrombosis | 2.3 | 1 | Citations (PDF) |
| 387 | Prevention of Restenosis by Local Drug Delivery | 2.5 | 1 | Citations (PDF) |
| 388 | Inhibition of Acute Stent Thrombosis Under High-Shear Flow Conditions by a Nitric Oxide Donor, DMHD/NO | 18.0 | 21 | Citations (PDF) |
| 389 | Effects of thermal exposure on binding of heparin in vitro to the arterial wall and to clot and on the chronic angiographic luminal response to local application of a heparin film during angioplasty in an in vivo rabbit model | 2.1 | 7 | Citations (PDF) |
| 390 | Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs | 16.5 | 704 | Citations (PDF) |
| 391 | Left-sided Femoral Venous Access for Tricuspid Clip Procedure | 1.6 | 1 | Citations (PDF) |
| 392 | Left Main protection during very high risk Transcatheter Aortic Valve-in-Valve procedure. A Collaborative Registry. | 0.0 | 1 | Citations (PDF) |
| 393 | Transcatheter closure of aorto-right atrial fistula | 0.5 | 0 | Citations (PDF) |
| 394 | Comprehensive Unified Regimen for Eliminating Undiagnosed/Untreated Aortic Valve Stenosis: Algorithm Validation for Identifying Aortic Stenosis and Treatment Disparities | 1.6 | 0 | Citations (PDF) |
| 395 | Transcatheter Treatment of Bicuspid Aortic Valve Stenosis: From Observational Studies to Randomized Clinical Trials | 1.6 | 3 | Citations (PDF) |
| 396 | Mitral transcatheter edge-to-edge repair in patients with severe pulmonary hypertension | 2.8 | 0 | Citations (PDF) |
| 397 | One-year outcomes of the RESILIA balloon-expandable transcatheter valve: survival, hemodynamics, and hypoattenuated leaflet thickening | 3.4 | 0 | Citations (PDF) |
| 398 | Design and rationale of the prospective, randomized, controlled trial to assess the management of moderate aortic stenosis by clinical surveillance or transcatheter aortic valve replacement: The PROGRESS Trial | 2.9 | 0 | Citations (PDF) |
| 399 | Effectiveness of Cerebral Embolic Protection During TAVR in Patients With High Aortic Valve Calcium Burden | 3.0 | 0 | Citations (PDF) |
| 400 | Remembering James Forrester | 2.3 | 0 | Citations (PDF) |
| 401 | Advances in the diagnosis and management of aortic stenosis | 0.2 | 0 | Citations (PDF) |
| 402 | Case report: Salvage transcatheter aortic valve replacement for acute aortic regurgitation due to prosthetic valve endocarditis | 0.0 | 0 | Citations (PDF) |
